Biotechnology Industry's Movers and Shakers

Biotechnology: The University-Industrial Complex. Martin Kenney. Yale University Press, New Haven, CT, 1986. 324 pp. $23.95. Divergent economic pressures on university scientists fueled the development of small biotechnology companies and thus the entire fledgling industry. Pressures came in one form as a need to gather support for research; in another, from the realization that molecular biology could make money. In this way, a new academic "industry" world was created. This concept is the thes

Written byJulian Davies
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

This concept is the thesis of Martin Kenney's Biotechnology. There are many things I like about the book. It expands on this framework and logically chronicles the development of many university-industry relationships and their positive and negative aspects. Tables provide useful information about the financial and personal aspects of these unique linkages.

The author identifies and analyzes the problems raised by such close associations of universities, faculty, students and administrations with industry. He emphasizes accurately the conflicts of academic and commercial interest, both inside and outside of the university.

The book moves from early business developments, to the response of university leaders to entrepreneurial initiatives by their staffs, the role of venture capital, and the increasing role of multinational organizations. There is a separate chapter on agriculture and biotechnology (Kenney is an associate professor of agricultural economics at Ohio State) and it is a relief to see that the author ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies